AK105 Combined With Anlotinib in Patients With Cervical Cancer (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=36 | Active, not recruiting | Sponsor: The First Affiliated Hospital of Zhengzhou University | Not yet recruiting ➔ Active, not recruiting | Trial completion date: Sep 2024 ➔ Dec 2027
Enrollment closed • Trial completion date • Cervical Cancer • Oncology • Solid Tumor • PD-L1
|